Skip to main content
CAI logo

CAI · Caris Life Sciences, Inc. · Earnings Calls, Transcripts & Webcasts

Track CAI — free
$17.58 -0.96 (-5.18%) At close · Nov 20 Play latest call Q3 2026 earnings call transcript
Market Cap
$5.04B
Shares
286.78M
Volume · Nov 20 4.57M Avg daily vol (3M) 4.64M

Caris Life Sciences, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Caris Life Sciences, Inc. (CAI), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Earnings call
FY26 · Q3
2026-11-04
Caris Life Sciences, Inc. (CAI) Q3 2026 Earnings Call Transcript
Confident tone Monitoring and MRD launches Early-stage detection rollout Clinical evidence and digital AI platform
Revenue
$275.36M
▲ 27% YoY
Diluted EPS
$0.05
▼ 37.5% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q2
2026-08-05
Caris Life Sciences, Inc. (CAI) Q2 2026 Earnings Call Transcript
Confident tone Record clinical volume and case growth Reimbursement and coverage Financial performance and profitability
Revenue
$263.71M
▲ 45.4% YoY
Diluted EPS
$0.00
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-08
Caris Life Sciences, Inc. (CAI) June 8, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-05-12
Caris Life Sciences, Inc. (CAI) May 12, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-07
Caris Life Sciences, Inc. (CAI) Q1 2026 Earnings Call Transcript
Confident tone MRD pipeline Profitability and cash generation New product launches
Revenue
$216.17M
▲ 78.8% YoY
Diluted EPS
$0.00
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-26
Caris Life Sciences, Inc. (CAI) Q4 2025 Earnings Call Transcript
Confident tone Profitability and cash flow Guidance and investment pacing Commercial expansion
Revenue
$292.89M*
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-05
Caris Life Sciences, Inc. (CAI) Q3 2025 Earnings Call Transcript
Confident tone Whole Exome and Whole Transcriptome platform MRD and monitoring pipeline Revenue growth and case volumes
Revenue
$216.83M
▲ 113.4% YoY
Diluted EPS
$0.08
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-12
Caris Life Sciences, Inc. (CAI) Q2 2025 Earnings Call
Revenue
$181.40M
▲ 81.3% YoY
Diluted EPS
$-7.97
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–8 of 8 webcasts
Key facts CIK 2019410 CUSIP 142152107 13F (30d) 312 filings 296 filers Visit website Investor relations